SNDX EBITDA
Syndax Pharmaceuticals Inc · EBITDA
SNDX EBITDA
Latest reported-$135.24Mperiod ending
SNDX TTM EBITDA (-$8.56M → -$135.24M)
TTM EBITDA
High-resolution chart · PNG
SNDX ebitda history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | EBITDA (USD) |
|---|---|
| -135,243,000 | |
| -162,495,000 | |
| -224,455,000 | |
| -298,509,000 | |
| -330,181,000 | |
| -334,262,000 | |
| -313,821,000 | |
| -296,865,000 | |
| -263,837,000 | |
| -240,399,000 | |
| -209,140,000 | |
| -175,881,000 | |
| -158,455,000 | |
| -150,744,000 | |
| -146,168,000 | |
| -10,812,000 | |
| 2,853,000 | |
| 17,452,000 | |
| 26,875,000 | |
| -89,193,000 | |
| -88,990,000 | |
| -83,125,000 | |
| -70,805,000 | |
| -64,704,000 | |
| -57,704,000 | |
| -56,218,000 | |
| -55,576,000 | |
| -60,790,000 | |
| -65,707,000 | |
| -69,667,000 | |
| -75,234,000 | |
| -75,983,000 | |
| -73,579,000 | |
| -68,472,000 | |
| -61,954,000 | |
| -53,296,000 | |
| -53,242,000 | |
| -48,103,000 | |
| -43,632,000 | |
| -39,267,000 | |
| -29,697,000 | |
| -26,092,000 | |
| -21,730,000 | |
| -18,316,000 | |
| -20,380,000 | |
| -21,676,000 | |
| -21,317,000 | |
| -20,907,000 | |
| -15,458,000 | |
| -11,232,000 | |
| -8,558,000 | |
| -5,684,008 |